Top

BMC Medical Genetics

Published in:

Open Access 01-12-2014 | Research article

Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G > C as the most common mutation

Authors: Xiao Liu, Zhaoxia Wang, Weina Jin, He Lv, Wei Zhang, Chengli Que, Yu Huang, Yun Yuan

Published in: BMC Medical Genetics | Issue 1/2014

Abstract

Background

Pompe disease is an autosomal recessive lysosomal glycogen storage disorder that has been reported in different ethnic populations which carry different common mutations of the acid alpha-glucosidase (GAA) gene. The GAA mutation pattern in mainland Chinese patients with late-onset Pompe disease is still not well understood.

Methods

We presented the clinical and genetic characteristics of 27 mainland Chinese late-onset Pompe patients from 24 families.

Results

GAA mutation analysis revealed 26 different mutations, including 10 that were novel. The allelic frequency of c.2238G > C (p.W746C) was found to be 27.08% in this patient group. Respiratory dysfunction was diagnosed in 10 of 11 patients who underwent pulmonary function evaluation, although only four required ventilator support at night.

Conclusions

Our findings indicate that c.2238G > C (p.W746C) is the most common mutation in mainland Chinese late-onset Pompe patients, as observed in Taiwanese patients. The novel mutations identified in this study expand the genetic spectrum of late-onset Pompe disease, and the prevalence of respiratory dysfunction highlights the importance of monitoring pulmonary function in late-onset Pompe patients.

Available only for authorised users

Fuller DD, ElMallah MK, Smith BK, Corti M, Lawson LA, Falk DJ, Byrne BJ: The respiratory neuromuscular system in Pompe disease. Respir Respir Physiol Neurobiol. 2013, 189: 241-249. 10.1016/j.resp.2013.06.007.CrossRefPubMed

Ansong AK, Li JS, Nozik-Grayck E, Ing R, Kravitz RM, Idriss SF, Kanter RJ, Rice H, Chen YT, Kishnani PS: Electrocardiographic response to enzyme replacement therapy for Pompe disease. Genet Med. 2006, 8: 297-301. 10.1097/01.gim.0000195896.04069.5f.CrossRefPubMed

Müller-Felber W, Horvath R, Gempel K, Podskarbi T, Shin Y, Pongratz D, Walter MC, Baethmann M, Schlotter-Weigel B, Lochmüller H, Schoser B: Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Neuromuscul Disord. 2007, 17: 698-706. 10.1016/j.nmd.2007.06.002.CrossRefPubMed

Laforêt P, Nicolino M, Eymard PB, Puech JP, Caillaud C, Poenaru L, Fardeau M: Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation. Neurology. 2000, 55: 1122-1128. 10.1212/WNL.55.8.1122.CrossRefPubMed

Kroos M, Hoogeveen-Westerveld M, van der Ploeg A, Reuser AJ: The genotype–phenotype correlation in Pompe disease. Am J Med Genet C: Semin Med Genet. 2012, 160C: 59-68. 10.1002/ajmg.c.31318.CrossRef

Raben N, Plotz P, Byrne BJ: Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). Curr Mol Med. 2002, 2: 145-166. 10.2174/1566524024605789.CrossRefPubMed

Kroos MA, Van der Kraan M, Van Diggelen OP, Kleijer WJ, Reuser AJ, Van den Boogaard MJ, Ausems MG, van Amstel HK P, Poenaru L, Nicolino M: Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients. J Med Genet. 1995, 32: 836-837. 10.1136/jmg.32.10.836-a.CrossRefPubMedPubMedCentral

Montalvo AL, Bembi B, Donnarumma M, Filocamo M, Parenti G, Rossi M, Merlini L, Buratti E, De Filippi P, Dardis A, Stroppiano M, Ciana G, Pittis MG: Mutation profile of the GAA gene in 40 Italian patients with late onset glycogen storage disease type II. Hum Mutat. 2006, 27: 999-1006. 10.1002/humu.20374.CrossRefPubMed

Gort L, Coll MJ, Chabás A: Glycogen storage disease type II in Spanish patients: high frequency of c.1076-1GC mutation. Mol Genet Metab. 2007, 92: 183-187. 10.1016/j.ymgme.2007.05.011.CrossRefPubMed

10.

Joshi PR, Gläser D, Schmidt S, Vorgerd M, Winterholler M, Eger K, Zierz S, Deschauer M: Molecular diagnosis of German patients with late-onset glycogen storage disease type II. J Inherit Metab Dis. 2008, 31 (Suppl 2): 261-265. 10.1007/s10545-008-0820-2.CrossRef

11.

Huie ML, Chen AS, Tsujino S, Shanske S, DiMauro S, Engel AG, Hirschhorn R: Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-->G) mutation in a majority of patients and a novel IVS10 (+1GT-->CT) mutation. Hum Mol Genet 1994, 3:2231–2236.,

12.

Yang CC, Chien YH, Lee NC, Chiang SC, Lin SP, Kuo YT, Chen SS, Jong YJ, Hwu WL: Rapid progressive course of later-onset Pompe disease in Chinese patients. Mol Genet Metab. 2011, 104: 284-288. 10.1016/j.ymgme.2011.06.010.CrossRefPubMed

13.

Wens SC, van Gelder CM, Kruijshaar ME, de Vries JM, van der Beek NA, Reuser AJ, van Doorn PA, van der Ploeg AT, Brusse E: Phenotypical variation within 22 families with Pompe disease. Orphanet J Rare Dis. 2013, 8: 182-10.1186/1750-1172-8-182.CrossRefPubMedPubMedCentral

14.

Hanisch F, Rahne T, Plontke SK: Prevalence of hearing loss in patients with late-onset Pompe disease: Audiological and otological consequences. Int J Audiol. 2013, 52: 816-823. 10.3109/14992027.2013.840932.CrossRefPubMed

15.

Remiche G, Ronchi D, Magri F, Lamperti C, Bordoni A, Moggio M, Bresolin N, Comi GP: Extended phenotype description and new molecular findings in late onset glycogen storage disease type II: a northern Italy population study and review of the literature. J Neurol. 2014, 261: 83-97. 10.1007/s00415-013-7137-2.CrossRefPubMed

16.

Liu Q, Zhao J, Wang ZX, Zhang W, Yuan Y: Clinical features and acid alpha-glucosidase gene mutation in 7 Chinese patients with glycogen storage disease type II. Zhonghua Yi Xue Za Zhi. 2013, 93: 1981-1985. ChinesePubMed

17.

Jin W, Que C, Tang H, Huang Y, Wang Z, Liu X, Lv H, Zhang W, Yuan Y: Clinical study of respiratory function in patients with late-onset glycogen storage disease type II. Chinese J Contemp Neurol Neurosurg. 2014, 14: 399-404. Chinese

18.

Yang J, Cao J, Liu Z, Zhan Y, Liang Y, Mo G, Li Y, Sun Y, Li M, Li J, Zhang C: Clinical features and genetic analysis of 7 patients with late-onset glycogen storage disease type II. Chinese J Contemp Neurol Neurosurg. 2014, 14: 405-410. Chinese

19.

Kallwass H, Carr C, Gerrein J, Titlow M, Pomponio R, Bali D, Dai J, Kishnani P, Skrinar A, Corzo D, Keutzer J: Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots. Mol Genet Metab. 2007, 90: 449-452. 10.1016/j.ymgme.2006.12.006.CrossRefPubMed

20.

Park HD, Lee DH, Choi TY, Lee YK, Lee SY, Kim JW, Ki CS, Lee YW: Three patients with glycogen storage disease type II and the mutational spectrum of GAA in Korean patients. Ann Clin Lab Sci. 2013, 43: 311-316.PubMed

21.

Loureiro Neves F, Garcia PC, Madureira N, Araújo H, Rodrigues F, Estêvão MH, Lacerda L, Diogo Matos LM: Juvenile pompe disease: retrospective clinical study. Acta Med Port. 2013, 26: 361-370.PubMed

22.

Oda E, Tanaka T, Migita O, Kosuga M, Fukushi M, Okumiya T, Osawa M, Okuyama T: Newborn screening for Pompe disease in Japan. Mol Genet Metab. 2011, 104: 560-565. 10.1016/j.ymgme.2011.09.002.CrossRefPubMed

23.

Becker JA, Vlach J, Raben N, Nagaraju K, Adams EM, Hermans MM, Reuser AJ, Brooks SS, Tifft CJ, Hirschhorn R, Huie ML, Nicolino M, Plotz PH: The African origin of the common mutation in African American patients with glycogen-storage disease type II. Am J Hum Genet. 1998, 62: 991-994. 10.1086/301788.CrossRefPubMedPubMedCentral

24.

Fu L, Qiu W, Yu Y, Guo Y, Zhao P, Zhang X, Liu C, Li F, Huang H, Huang M, Chen S: Clinical and molecular genetic study of infantile-onset Pompe disease in Chinese patients: identification of 6 novel mutations. Gene. 2014, 535: 53-59. 10.1016/j.gene.2013.10.066.CrossRefPubMed

25.

Herzog A, Hartung R, Reuser AJ, Hermanns P, Runz H, Karabul N, Gökce S, Pohlenz J, Kampmann C, Lampe C, Beck M, Mengel E: A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations. Orphanet J Rare Dis. 2012, 7: 35-10.1186/1750-1172-7-35.CrossRefPubMedPubMedCentral

26.

Gaeta M, Barca E, Ruggeri P, Minutoli F, Rodolico C, Mazziotti S, Milardi D, Musumeci O, Toscano A: Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function. Mol Genet Metab. 2013, 110: 290-296. 10.1016/j.ymgme.2013.06.023.CrossRefPubMed

27.

Schneider I, Hanisch F, Müller T, Schmidt B, Zierz S: Respiratory function in late-onset Pompe disease patients receiving long-term enzyme replacement therapy for more than 48 months. Wien Med Wochenschr. 2013, 163: 40-44. 10.1007/s10354-012-0153-5.CrossRefPubMed

28.

Preisler N, Lukacs Z, Vinge L, Madsen KL, Husu E, Hansen RS, Duno M, Andersen H, Laub M, Vissing J: Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies. Mol Genet Metab. 2013, 110: 287-289. 10.1016/j.ymgme.2013.08.005.CrossRefPubMed

29.

Vissing J, Lukacs Z, Straub V: Diagnosis of Pompe disease: muscle biopsy vs blood-based assays. JAMA Neurol. 2013, 70: 923-927. 10.1001/2013.jamaneurol.486.CrossRefPubMed

30.

Kishnani PS, Amartino HM, Lindberg C, Miller TM, Wilson A, Keutzer J: Methods of diagnosis of patients with Pompe disease: Data from the Pompe Registry. Mol Genet Metab. 2014, 113: 84-91. 10.1016/j.ymgme.2014.07.014.CrossRefPubMed

Title: Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G > C as the most common mutation
Authors: Xiao Liu
Zhaoxia Wang
Weina Jin
He Lv
Wei Zhang
Chengli Que
Yu Huang
Yun Yuan
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: BMC Medical Genetics / Issue 1/2014
Electronic ISSN: 1471-2350
DOI: https://doi.org/10.1186/s12881-014-0141-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G > C as the most common mutation

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2014

Functional polymorphism in aldehyde dehydrogenase-2 gene associated with risk of tuberculosis

A novel GLI3 mutation affecting the zinc finger domain leads to preaxial-postaxial polydactyly-syndactyly complex

The chromosome 9p21 variant interacts with vegetable and wine intake to influence the risk of cardiovascular disease: a population based cohort study

A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival

A simple method for gene phasing using mate pair sequencing

Identification of CDH23 mutations in Korean families with hearing loss by whole-exome sequencing